Colorectal cancer patients with lower exosomal CPNE3 levels had substantially better disease-free survival and overall survival, implying that CPNE3 is a diagnostic and prognostic biomarker (Sun et al., 2019). This evidence concerns the gene CPNE3 and colorectal cancer.